Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

Presentation TCT 2024

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Presenter: Sem Rikken

October 30, 2024

Presentation TCT 2024

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Presenter: Kari Saville

October 30, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

Presenter: Kyriakos Dimitriadis

October 29, 2024

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

TCT 824: TAVI on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment

Presenter: Iulia Tustiu

October 29, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

TCT 319: Coronary Rotational Atherectomy Elective vs. Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure Trial

Presenter: Borja Rivero-Santana

October 28, 2024

Advertisement

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What Evaluation is Required for Patient Selection for RDN?

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 824: TAVI on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment

What’s Next - Going into 2025

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Getting Started: Establishing a Patient Care Pathway

Science of Ultrasound RDN

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

TCT 319: Coronary Rotational Atherectomy Elective vs. Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content